Abstract: Cordyceps sinensis , an important medicinal fungus in traditional Chinese medicine, has gained increasing attention for its diverse pharmacological activities, particularly its anti-inflammatory properties. Its principal bioactive components, including cordycepin, cordycepic acid, polysaccharides, and sterols, exert significant protective effects in a wide range of inflammation-related diseases, primarily covering respiratory diseases, autoimmune disorders, neuroinflammatory conditions, and metabolic and gastrointestinal syndromes. These compounds act mainly by modulating key signaling pathways, including NF-κB, MAPK, TLR4/MyD88, PI3K/Akt, JAK/STAT, and Nrf2/HO-1. This review summarizes recent progress in the identification of anti-inflammatory components of Cordyceps sinensis and their mechanisms of action, highlights current challenges in clinical translation, and outlines future research directions. Collectively, these findings emphasize the broad potential of Cordyceps sinensis as a multi-target natural product–based anti-inflammatory therapy. Keywords: Cordyceps sinensis , bioactive components, anti-inflammatory mechanisms, inflammation-related diseases
Xie et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: